Epatopatia HCV-correlata in emodialisi

manifestazioni biochimiche e cliniche

Translated title of the contribution: HCV-related liver disease in hemodialysis population: clinical and biochemical characteristic

F. Fabrizi, P. Martin, G. Lunghi, L. Guerra, A. F. De Vecchi, C. Ponticelli

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) infection remains frequent among patients on maintenance dialysis. It has been claimed that infrequent and slight abnormalities in serum aminotransferase activity could occur in dialysis patients with HCV. We describe a 61-year-old male patient on maintenance dialysis who acquired HCV by a nosocomial route. The natural history of HCV in this patient over 8 yrs featured frequent and high increases in serum aminotransferase and gamma-glutamyl transpeptidase (gamma-GT) levels. In December 2001, serum GOT and GPT were, respectively, 965 and 1294 UI/L; gamma-GT activity was 241 UI/L. HCV genotype was 2a/2c; median HCV RNA values in serum were 2.3 x 10⁵ UI/mL (range, 1.14 x 10⁴ to 4.6 x 10⁵ UI/mL). Total bilirubin, serum albumin, and colinesterase levels remained normal over the entire follow-up. Liver biopsy was not performed and interferon (IFN) therapy was not given. Currently, biochemical liver tests (GOT/GPT/gamma-GT) are in the upper range of normal values and the patient remains viremic. Efficacy and tolerability of initial monotherapy with IFN for chronic hepatitis C among dialysis patients are briefly discussed. Further studies are warranted to define the optimal anti-viral regimen for chronic hepatitis C in the dialysis population.

Original languageItalian
Pages (from-to)483-487
Number of pages5
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Volume21
Issue number5
Publication statusPublished - Sep 1 2004

Fingerprint

Hepacivirus
Renal Dialysis
Liver Diseases
Dialysis
gamma-Glutamyltransferase
Population
Chronic Hepatitis C
Transaminases
Serum
Interferons
Maintenance
Liver
Virus Diseases
Natural History
Bilirubin
Serum Albumin
Reference Values
Genotype
RNA
Biopsy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epatopatia HCV-correlata in emodialisi : manifestazioni biochimiche e cliniche. / Fabrizi, F.; Martin, P.; Lunghi, G.; Guerra, L.; De Vecchi, A. F.; Ponticelli, C.

In: Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia, Vol. 21, No. 5, 01.09.2004, p. 483-487.

Research output: Contribution to journalArticle

@article{e55d1d5fe6bf4e70a07b8afc3301dfb8,
title = "Epatopatia HCV-correlata in emodialisi: manifestazioni biochimiche e cliniche",
abstract = "Hepatitis C virus (HCV) infection remains frequent among patients on maintenance dialysis. It has been claimed that infrequent and slight abnormalities in serum aminotransferase activity could occur in dialysis patients with HCV. We describe a 61-year-old male patient on maintenance dialysis who acquired HCV by a nosocomial route. The natural history of HCV in this patient over 8 yrs featured frequent and high increases in serum aminotransferase and gamma-glutamyl transpeptidase (gamma-GT) levels. In December 2001, serum GOT and GPT were, respectively, 965 and 1294 UI/L; gamma-GT activity was 241 UI/L. HCV genotype was 2a/2c; median HCV RNA values in serum were 2.3 x 10⁵ UI/mL (range, 1.14 x 10⁴ to 4.6 x 10⁵ UI/mL). Total bilirubin, serum albumin, and colinesterase levels remained normal over the entire follow-up. Liver biopsy was not performed and interferon (IFN) therapy was not given. Currently, biochemical liver tests (GOT/GPT/gamma-GT) are in the upper range of normal values and the patient remains viremic. Efficacy and tolerability of initial monotherapy with IFN for chronic hepatitis C among dialysis patients are briefly discussed. Further studies are warranted to define the optimal anti-viral regimen for chronic hepatitis C in the dialysis population.",
author = "F. Fabrizi and P. Martin and G. Lunghi and L. Guerra and {De Vecchi}, {A. F.} and C. Ponticelli",
year = "2004",
month = "9",
day = "1",
language = "Italian",
volume = "21",
pages = "483--487",
journal = "Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia",
issn = "0393-5590",
publisher = "Wichtig Publishing Srl",
number = "5",

}

TY - JOUR

T1 - Epatopatia HCV-correlata in emodialisi

T2 - manifestazioni biochimiche e cliniche

AU - Fabrizi, F.

AU - Martin, P.

AU - Lunghi, G.

AU - Guerra, L.

AU - De Vecchi, A. F.

AU - Ponticelli, C.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Hepatitis C virus (HCV) infection remains frequent among patients on maintenance dialysis. It has been claimed that infrequent and slight abnormalities in serum aminotransferase activity could occur in dialysis patients with HCV. We describe a 61-year-old male patient on maintenance dialysis who acquired HCV by a nosocomial route. The natural history of HCV in this patient over 8 yrs featured frequent and high increases in serum aminotransferase and gamma-glutamyl transpeptidase (gamma-GT) levels. In December 2001, serum GOT and GPT were, respectively, 965 and 1294 UI/L; gamma-GT activity was 241 UI/L. HCV genotype was 2a/2c; median HCV RNA values in serum were 2.3 x 10⁵ UI/mL (range, 1.14 x 10⁴ to 4.6 x 10⁵ UI/mL). Total bilirubin, serum albumin, and colinesterase levels remained normal over the entire follow-up. Liver biopsy was not performed and interferon (IFN) therapy was not given. Currently, biochemical liver tests (GOT/GPT/gamma-GT) are in the upper range of normal values and the patient remains viremic. Efficacy and tolerability of initial monotherapy with IFN for chronic hepatitis C among dialysis patients are briefly discussed. Further studies are warranted to define the optimal anti-viral regimen for chronic hepatitis C in the dialysis population.

AB - Hepatitis C virus (HCV) infection remains frequent among patients on maintenance dialysis. It has been claimed that infrequent and slight abnormalities in serum aminotransferase activity could occur in dialysis patients with HCV. We describe a 61-year-old male patient on maintenance dialysis who acquired HCV by a nosocomial route. The natural history of HCV in this patient over 8 yrs featured frequent and high increases in serum aminotransferase and gamma-glutamyl transpeptidase (gamma-GT) levels. In December 2001, serum GOT and GPT were, respectively, 965 and 1294 UI/L; gamma-GT activity was 241 UI/L. HCV genotype was 2a/2c; median HCV RNA values in serum were 2.3 x 10⁵ UI/mL (range, 1.14 x 10⁴ to 4.6 x 10⁵ UI/mL). Total bilirubin, serum albumin, and colinesterase levels remained normal over the entire follow-up. Liver biopsy was not performed and interferon (IFN) therapy was not given. Currently, biochemical liver tests (GOT/GPT/gamma-GT) are in the upper range of normal values and the patient remains viremic. Efficacy and tolerability of initial monotherapy with IFN for chronic hepatitis C among dialysis patients are briefly discussed. Further studies are warranted to define the optimal anti-viral regimen for chronic hepatitis C in the dialysis population.

UR - http://www.scopus.com/inward/record.url?scp=84941740501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941740501&partnerID=8YFLogxK

M3 - Articolo

VL - 21

SP - 483

EP - 487

JO - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

JF - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

SN - 0393-5590

IS - 5

ER -